FIELD: medicine, cardiology.
SUBSTANCE: invention proposes an agent for correction of abdominal complications in acute period in myocardium infarction. Proposed agent represents ondansetron or domperidone. Agent reduces frequency of hyperemia occurring, improved indices of intestine contractions, promotes to declining lethality in acute period in myocardium infarction.
EFFECT: improved and valuable medicinal properties of agent.
4 tbl, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| CORONARY ACTIVE ANTI-ISCHEMIA AND ANTI-ARRHYTHMIA AGENT | 2005 |
|
RU2290927C1 |
| PHARMACOLOGICALLY ACTIVE SUBSTANCE OF ORGANISM-PROTECTION MATERIAL, METHOD OF PREPARATION THEREOF, AND THERAPEUTIC APPLICATION | 1990 |
|
RU2104704C1 |
| METHOD FOR MODELING STOMACH AND INTESTINE ULCERATION | 2004 |
|
RU2269161C2 |
| METHOD FOR REPRODUCING CARDIOGENIC SHOCK IN SMALL-SIZED LABORATORY ANIMALS | 2003 |
|
RU2239874C1 |
| GAMMA-HYDROXYPROPYLAMMONIUM-5-HYDROXYNICOTINATE ELICITING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND HYPOLIPIDEMIC ACTIVITY | 2003 |
|
RU2245329C1 |
| METHOD OF REGULATORY ACTION ON PRIMARY MECHANISMS OF BODY DEFENSE REACTIONS IN NORMAL AND PATHOLOGICAL STATES: IMMUNE REACTION, INFLAMMATORY REACTIONS, AND FREE-RADICAL PROCESS USING GAMMA-GLUTAMYLHISTAMINE | 1999 |
|
RU2180842C2 |
| METHOD FOR PREPARING PATIENTS TO VIDEOCAPSULAR ENDOSCOPIC EXAMINATION | 2004 |
|
RU2269343C1 |
| ORAL PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY GASTROINTESTINAL DISEASES | 2010 |
|
RU2445965C2 |
| APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
| METHOD FOR EXPERIMENTAL SIMULATION OF STRESS-INDUCED DEVELOPMENT OF ACUTE ULCER BLEEDING | 2011 |
|
RU2472231C1 |
